I don't disagree with your opinion. But, I find it ironic that when Joe embarked on this spin-off scheme to unlock the real value of NGIO there was no COVID. So now NGIO has created a COVID vaccine and a potential revenue stream where there was none ... and should add value. But it seems everything hinges on this bonus opportunity ...